VolitionRX Ltd (AMEX:VNRX) shares, rose in value on Thursday, April 16, with the stock price down by -2.00% to the previous day’s close as strong demand from buyers drove the stock to $0.49.
Actively observing the price movement in the last trading, the stock closed the session at $0.50, falling within a range of $0.46 and $0.51. The value of beta (5-year monthly) was 1.162. Referring to stock’s 52-week performance, its high was $1.02, and the low was $0.42. On the whole, VNRX has fluctuated by -12.03% over the past month.
With the market capitalization of VolitionRX Ltd currently standing at about $49.36 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-30.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VNRX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of VNRX currently trading nearly -5.48% and -12.38% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.65, while the 7-day volatility ratio is showing 10.82% which for the 30-day chart, stands at 11.44%. Furthermore, VolitionRX Ltd (VNRX)’s beta value is 1.00, and its average true range (ATR) is 0.06.
A comparison of VolitionRX Ltd (VNRX) with its peers suggests the former has fared considerably weaker in the market. VNRX showed an intraday change of -2.00% in last session, and over the past year, it shrunk by -20.97%%.
Data on historical trading for VolitionRX Ltd (AMEX:VNRX) indicates that the trading volumes over the past 10 days have averaged 0.44 and over the past 3 months, they’ve averaged 170.61K. According to company’s latest data on outstanding shares, there are 96.10 million shares outstanding.
Nearly 25.96% of VolitionRX Ltd’s shares belong to company insiders and institutional investors own 21.16% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.69 million shares as on 2025-03-31, resulting in a short ratio of 5.11. According to the data, the short interest in VolitionRX Ltd (VNRX) stood at 88.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.58 million. The stock has fallen by -18.33% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VNRX stock heading into the next quarter.
